Literature DB >> 11927000

Characteristics of bovine hemoglobin as a potential source of hemoglobin-vesicles for an artificial oxygen carrier.

Hiromi Sakai1, Yohei Masada, Shinji Takeoka, Eishun Tsuchida.   

Abstract

Hemoglobin-vesicles (HbV) have been developed for use as artificial O(2) carriers in which a purified Hb solution is encapsulated within a phospholipid bilayer membrane. In this study, bovine Hb (BHb) was tested as a source of HbV instead of human Hb (HHb). We compared the preparation process and characteristics of BHbV with those of HHbV. The purification of BHb was effectively performed simply with an ultrafiltration system including a process for removing virus and scrapie reagent. The removal ratio of the phospholipid components of bovine red blood cells was over 99.99%, and the protein purity was over 99.9%. The deoxygenated and carbonylated BHb showed denaturation transition temperatures at 83 and 87 degrees C, respectively, which are higher than those of HHb (80 and 78 degrees C, respectively), and resistant to pasteurization (60 degrees C, 10 h). The purified BHb was concentrated to over 40 g/dl, and encapsulated in a phospholipid bilayer membrane to form BHbV with a diameter of about 280 nm. The O(2) affinity (P(50)) of the BHbV was regulated by coencapsulation of an appropriate amount of Cl(-) (as NaCl), which binds to BHb as an allosteric effector, in the range 16-28 Torr, comparable to human blood (P(50) = 28 Torr). This is quite simple in comparison with HHb which requires phosphate derivatives such as pyridoxal 5'-phosphate as a replacement for 2,3-diphoshoglyceric acid. The viscosity and colloid osmotic pressure of the BHbV when suspended in 5% human serum albumin are 3.5 cP and 20 Torr, respectively, comparable to those of human blood. In conclusion, BHb can be used as a source for the production of HbV, not only because of its abundance in the cattle industry, but also because of the physicochemical advantages of the purification process, thermal stability, and regulation of O(2) affinity in comparison with HHb.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927000     DOI: 10.1093/oxfordjournals.jbchem.a003141

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.

Authors:  Thomas Ming Swi Chang
Journal:  Biochim Biophys Acta       Date:  2008-06-17

2.  Simple method for preparing poly(ethylene glycol)-surface-conjugated liposome-encapsulated hemoglobins: physicochemical properties, long-term storage stability, and their reactions with O2, CO, and NO.

Authors:  Shahid Rameez; Andre F Palmer
Journal:  Langmuir       Date:  2011-06-16       Impact factor: 3.882

3.  2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.

Authors:  Anirban Sen Gupta
Journal:  Shock       Date:  2017-09-29       Impact factor: 3.454

4.  Large scale production of vesicles by hollow fiber extrusion: a novel method for generating polymersome encapsulated hemoglobin dispersions.

Authors:  Shahid Rameez; Ibrahim Bamba; Andre F Palmer
Journal:  Langmuir       Date:  2010-04-06       Impact factor: 3.882

5.  Low modulus biomimetic microgel particles with high loading of hemoglobin.

Authors:  Kai Chen; Timothy J Merkel; Ashish Pandya; Mary E Napier; J Christopher Luft; Will Daniel; Sergei Sheiko; Joseph M DeSimone
Journal:  Biomacromolecules       Date:  2012-08-17       Impact factor: 6.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.